相关实验视频
Updated: Jun 3, 2025

07:23
Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
Published on: March 7, 2022
5.8K
NPA7:一种双受体激活,可以抑制心脏氧化应激
Xiaoyu Ma1, Joute Chawngvawr Malsawmzuali1, Dante G Moroni1
1Cardiorenal Research Laboratory, Department of Cardiovascular Medicine (Xiaoyu Ma, J.C.M., D.G.M., Xiao Ma, Y.Z., S.P., Y.W., S.J.S., J.C.B.), Mayo Clinic, Rochester, MN.
Hypertension (Dallas, Tex. : 1979)
|January 8, 2025
概括
新型NPA7通过激活抗氧化途径,减少心脏细胞和高血压大鼠的氧化压力. 这种可以向GC-A/cGMP和MasR/cAMP通路,为心血管疾病提供潜在的治疗方法.
科学领域:
- 心血管研究研究心血管研究
- 分子生物学分子生物学
- 药理学 药理学 是一个学科.
背景情况:
- 心肌细胞氧化应激会加剧高血压引起的心力衰竭.
- 针对性治疗对于管理这种情况至关重要.
- 开发了一种新NPA7,可协同激活GC-A/cGMP和MasR/cAMP通路.
研究的目的:
- 研究NPA7在人类心肌细胞 (HCM) 和大鼠高血压模型中的抗氧化作用.
- 为了确定NPA7是否调节p62-KEAP1-NRF2通路.
- 探索GC-A,MasR和p62在NPA7的作用机制中的作用.
主要方法:
- 在HCM中诱导的氧化应激与H2O2;用NPA治疗7.7.
- 使用二乙染色评估反应性氧物种 (ROS).
- 对于p62,KEAP1,NRF2的西部涂抹;测量GSH/GSSG比率和抗氧化基因表达.
- 在HCM中利用siRNA进行GC-A,MasR,p62敲击.
- 在体内研究自发高血压大鼠 (SHRs) 和Wistar京都 (WKY) 大鼠,测量心脏氧化应激和相关的基因/蛋白质水平.
主要成果:
- 在HCM中,NPA7显著降低了H2O2诱导的ROS,并增加了GSH/GSSG比率.
- 沉默GC-A或MasR取消了NPA7的保护作用.
- NPA7激活了KEAP1-NRF2通路,增加了抗氧化基因表达; p62敲击破坏了这种激活.
- SHR心脏显示ROS升高,NPA7治疗减少了ROS.
- 在SHR心中,NPA7抑制了KEAP1蛋白水平,并降低了NOX2和p67mRNA.
结论:
- 在心血管应激的细胞和体内模型中,NPA7表现出强大的抗氧化特性.
- 该通过GC-A和MasR受体起作用,调节p62-KEAP1-NRF2通路.
- NPA7代表了一种有前途的治疗策略,用于减轻心血管疾病中的氧化应激.
相关概念视频
Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
381
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
381
G-Protein Gated Ion Channels
4.5K
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Sensory...
4.5K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
56
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
56

